Globally, the leading causes of natural death are attributed to coronary heart disease and
type 1 and type 2 diabetes. High blood pressure levels, high cholesterol levels, smoking …

Advances in stent design and the development of bioresorbable polymers have allowed the
development of novel stent technologies such as the Orsiro bioresorbable-polymer sirolimus …

Background Patients with diabetes have more extensive coronary disease, resulting in
higher risks of adverse clinical events following stenting. In all-comer patients, contemporary …

Although two randomized trials showed advantages for ultrathin-strut DES, other clinical
trials provided no significant evidence that ultrathin-strut DES improve clinical outcome. The …

Aim Patients with diabetes mellitus (DM) undergoing percutaneous coronary intervention
(PCI) remain at high risk of cardiovascular events despite the use of contemporary drug …

Background Diabetes mellitus is a risk for increased incidence of adverse clinical events
after percutaneous coronary intervention. However, the difference in the incidence of …

This sub‐study of the SORT OUT IX trial sought to compare clinical outcomes between
patients with diabetes randomized to implantation of either the polymer‐free biolimus A9 …

Background Patients with diabetes mellitus (DM) have worse outcomes following
percutaneous coronary intervention than nondiabetic patients. The novel Supreme DES is a …

INTRODUCTION—Coronary heart disease (CHD) is a major cause of morbidity and
mortality among patients with diabetes mellitus. Compared with nondiabetic patients …

Coronary Healing Patterns Following Stenting in Patients With Diabetes as Assessed by
Optical Coherence Tomography. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …